https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
INTRODUCTION A recent analysis derived from the PAMPer trial dataset demonstrated no significant independent plasma survival benefit in those who required massive transfusion ( ≥10 units of red cells in 24 hours). The definition of massive transfusion has evolved over time to minimize bias and predict those at highest risk of death. We sought to characterize the definition of massive transfusion, their associated mortality risks and the survival benefit associated with prehospital plasma. METHODS A secondary analysis w
Beğen
Yorum Yap
Paylaş
